Exscientia PLC (NAS:EXAI)
$ 5.04 -0.16 (-3.08%) Market Cap: 640.18 Mil Enterprise Value: 281.73 Mil PE Ratio: 0 PB Ratio: 1.66 GF Score: 40/100

Exscientia PLC at Bank of America AI and Disruptive Tech Conference Transcript

Nov 09, 2022 / 05:40PM GMT
Release Date Price: $6.86 (-0.87%)
Michael Leonidovich Ryskin
BofA Securities, Research Division - Director in Equity Research & Research Analyst

Great. Thank you for joining us, everyone. Let's try this again. For those of you that don't know me, I'm Mike Ryskin. I'm on the Life Science Tools and Diagnostics team here at Bank of America. And joining us for our next session, we're excited to have Andrew Hopkins, CEO and Founder of Exscientia. And as you can probably tell, it's a little bit of a different flavor to the next panel we're doing. This is -- the focus of this chat is going to be on artificial intelligence and drug discovery.

So Andrew, thanks so much for joining us.

Andrew L. Hopkins
Exscientia plc - Founder, CEO & Executive Director

Great to be here, Mike. Thanks much.

Questions & Answers

Michael Leonidovich Ryskin
BofA Securities, Research Division - Director in Equity Research & Research Analyst

Great. And the format of the session is going to be similar to what you've seen in some of your other talks

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot